Skip to main content

Brian M. Slomovitz, MD, MS

Brian S.
Interview
03/13/2025
A guest expert discusses groundbreaking research on pembrolizumab in adjuvant treatment for endometrial cancer, highlighting the significant impact on reducing recurrence risk in patients with deficient mismatch repair and the need for...
A guest expert discusses groundbreaking research on pembrolizumab in adjuvant treatment for endometrial cancer, highlighting the significant impact on reducing recurrence risk in patients with deficient mismatch repair and the need for...
A guest expert discusses...
03/13/2025
Journal of Clinical Pathways
Slomovitz Headshot
Interview
12/17/2024
In this interview, Brian M. Slomovitz, MD, MS, discusses the impact of molecular classification on endometrial cancer treatment, the role of biomarkers in guiding therapy, and the promise of emerging strategies to address challenges in...
In this interview, Brian M. Slomovitz, MD, MS, discusses the impact of molecular classification on endometrial cancer treatment, the role of biomarkers in guiding therapy, and the promise of emerging strategies to address challenges in...
In this interview, Brian M....
12/17/2024
Journal of Clinical Pathways